Redefining Infection Management. Proven Clinical Outcomes

Similar documents
No-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program

AHFA 2016 Regulatory Summit. Antimicrobial Material Preservatives & Sustainability Considerations

Today s Agenda: 9/30/14

Wound Management. Elof Eriksson MD PhD Professor Emeritus, Harvard Medical School Chief Medical Officer, Applied Tissue Technologies LLC

CLPNA Pressure Ulcers ecourse: Module 5.6 Quiz II page 1

Burn Infection & Laboratory Diagnosis

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

The Choice. V e r s a t i l i t y. S t r e n g t h. F l e x i b i l i t y. of surgeons for half a century

EcoHydra Antimicrobial Handwash. Product Overview. Physical Properties. Product Description. Regulatory Compliance. Key Features and Benefits

METRIGUARD. Technical Bulletin

CWHHE OOHS Wound Care Management Formulary November 2016 v1.1

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

Conflict of interest: We have no conflict of interest to report on this topic of SSI reduction for total knees.

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Author - Dr. Josie Traub-Dargatz

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Reducing Infections in Surgical Practice. Fred A Sweet, MD Rockford Spine Center Illinois, USA

Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus

General Rules Topicals for Skin Infections Topicals for Allergic Skin Disease Topicals for Seborrhea

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Biofilms no sign of infection but still not healing? <<Clinical Specialist>>

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

MANAGEMENT OF TOTAL JOINT ARTHROPLASTY INFECTIONS

3 Infection Prevention Solutions

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Antimicrobial Skin and Wound Care Products

Clinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: HIM*, Medicaid

Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare

COALINGA STATE HOSPITAL. NURSING POLICY AND PROCEDURE MANUAL SECTION Emergency Procedures POLICY NUMBER: 705. Effective Date: August 31, 2006

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

See Important Reminder at the end of this policy for important regulatory and legal information.

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

What Is Thought To Be The Problem?

Antibacterial Agents & Conditions. Stijn van der Veen

Why Don t These Drugs Work Anymore? Biosciences in the 21 st Century Dr. Amber Rice October 28, 2013

Diabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals

Two (II) Upon signature

Multi-Drug Resistant Organisms (MDRO)

Approved by the Food Safety Commission on September 30, 2004

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University

Randall Singer, DVM, MPVM, PhD

2016 Durable Medical Equipment Supplier Fee Schedule

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

Overview of Infection Control and Prevention

American Association of Feline Practitioners American Animal Hospital Association

MRSA Outbreak in Firefighters

FOUR STAGES OF HEALING & BEST USE OF SILVER WHINNYS

THE MOLECULAR GENETIC ANALYSIS OF

Silicone delivery liner assists easy release of 3M TM Ioban TM 2 Antimicrobial Incise Drape onto the skin.

running head: SUPERBUGS Humphreys 1

Other Beta - lactam Antibiotics

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

MICROBAN CLAIMS OVERVIEW

TABLE OF CONTENTS. 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process

TEAT DIP- POST DIP- PRE DIP- STRIPING

Effective Hatching Egg Sanitization. Craig D. Coufal, Ph.D.

BactiBarrier Testing and Analysis

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

Antibiotic Resistance

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Can you treat mrsa with amoxicillin

Dr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust

Clinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: Oregon Health Plan

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Veterinary. Advanced veterinary wound care

KILLS BACTERIA, FUNGI & VIRUSES INCLUDING: RINGWORM, PARVO VIRUS, AVIAN FLU, MRSA, E COLI, SALMONELLA TO NAME A FEW...

Ca-MRSA Update- Hand Infections. Washington Hand Society September 19, 2007

Cleaning and Disinfection Protocol Vegetative Bacteria

Dual Antibiotic Delivery from Chitosan Sponges Prevents In Vivo Polymicrobial Biofilm Infections

ANTIMICROBIAL STEWARDSHIP: THE ROLE OF THE CLINICIAN SAM GUREVITZ PHARM D, CGP BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES

STATISTICAL REPORT. Preliminary Analysis of the Second Collaborative Study of the Hard Surface Carrier Test

Standing Orders for the Treatment of Outpatient Peritonitis

Exploration of the Disinfection Hierarchy. Emily Mitchell, Chief Antimicrobials Branch

General Approach to Infectious Diseases

Antimicrobial Copper Touch Surfaces: A new tool for Infection Control and Prevention

WALKING BOOT, PNEUMATIC AND/OR VACUUM, WITH OR WITHOUT JOINTS, WITH OR WITHOUT INTERFACE MATERIAL, PREFABRICATED, INCLUDES FITTING AND ADJUSTMENT

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

TotalHealth. March 2015 Powered by TWIP The Wellness Imperative People Empowering People Through Education

Cleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria

An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?

These life-saving drugs have been a boon to medical care and benefited hundreds of million patients around the globe.

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

SYMMETRY ANTIMICROBIAL FOAMING HANDWASH with 0.3% PCMX Technical Data

The Spread of the Superbug

New and Innovative Applications for Metals COPPER. Tony Lea International Copper Association

Healthcare-associated infections surveillance report

Microbiology ( Bacteriology) sheet # 7

S aureus infections: outpatient treatment. Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium

Reduce the risk of recurrence Clear bacterial infections fast and thoroughly

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Problem: Hospital Acquired Infections

Transcription:

Proven Clinical Outcomes Proof of Bacteria-Binding1 In the first 30 seconds, 1 square centimeter of Cutimed Sorbact binds wound bacteria - after 2 hours, the amount of bacteria bound are more than would normally be found in an infected wound. Bound bacteria become inactivated, their metabolism slows down, they take a rest and do not continue to replicate. The formation of bacterial toxins also slows or stops completely which supports the wound healing process. In a lab porcine model, DACC-coated dressing showed more bacteria was removed than with Actisorb (non-dacc). Even Binds the Superbugs, MRSA4 DACC-coated dressings are effective in the removal of bacteria from wound beds, including MRSA. An in-vitro study that concluded A quantitatively high and stable initial adhesion to the microbial binding dressing was detected in all experiments involving Staphylococcus aureus strains, including nine MRSA strains. These findings strengthen the view that development of antibiotic resistance has minimal impact on the surface structures of the microorganism from a wound adhesion perspective. DACC vs. Silver 2 No signs of infection and cut the healing time by %. 80 patients - 0% treated with silver, 0% treated with. Patients were observed until wound healed, or total time of 4 months. Of the patients treated with silver, 12 of 38 patients developed signs of infection and the average healing time was days. Of the patients treated with, there were zero complications by infection and the average healing time was 12 days. Prevents Infection Equally effective to standard of care in preventing infections. 2,441 infants participated DACC was compared to the standard of care, chlorhexidine-ethanol antimicrobial. Cutimed Sorbact coated with was proven to be equally effective to standard of care in preventing infections with the purpose of preventing bacterial colonization in the umbilical area. Safe and Effective Wound Healing6 93% of the wounds improved or healed completely in the documented period. In the Kammerlander multi-center study with 116 colonized or infected wounds, Cutimed Sorbact with DACC Technology eliminated the infection signs in the majority of patients. Reduces Exudate, Odor and Pain7 Medical personal have reported exudate levels greatly improved, even for long-standing wounds that did not respond to prior treatments. Studies also show a considerable reduction in malodor in just over four weeks with Cutimed Sorbact and patients reported a significant reduction in pain over the treatment period. 1 RCT 7+ Peer-Reviewed Articles 2+ Posters + Case Studies 1. Ljungh, A. Yanagisawa, N. and Wadstrom, T. Using the principle of hydrophobic interaction to bind and remove wound bacteria. The Journal of Wound Care, April 06, Vol 1, No.4. 2. Corsi, Alessandro. Comparison of a novel non-mediated bacteria-binding dressing to silver dressings in the management of acute and chronic skin lesions. 3. Edwards R, Harding KG. (04). Bacteria and wound healing. Curr Opin Infect Dis 17:91-96. 4. Ronner, A.C., et.al.: Adhesion of methicillin-resistant Staphylococcus aureus to DACC-coated dressings, Journal of Wound Care, Vol. 23 / No., October 14.. Meberg A, Schoyen K. Hydrophobic material in routine umbilical cord care and prevention of infections in newborn infants. Scand J Infect Dis 22. 6. Kammerlander, G., Locherer, E., Süss-Burghart, A., von Hallern, B., Wipplinger, P. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. 7. Hampton, S. An evaluation of the efficacy of Cutimed Sorbact in different types of non-healing wounds. Wound UK. 07;3:1-6. BSN medical Inc. 82 Carnegie Blvd. Charlotte, NC 289-4633 Tel. 704 4 9933 Fax 704 38 48 www.bsnmedical.com To order toll-free: BSN medical 800 2 117 67 RN 1 BSN medical Inc. REV 03/1 Redefining Infection Management

Cutimed Sorbact Dressing Pads Absorbent core Exudate management Ribbon gauzes Size REF-No. Dressings/Box Suggested HCPCS* 2.8 x 3. in. (7 x 8.9 cm) 72161 2.8 x 3. in. (7 x 8.9 cm) 72160 4 x 4 in. ( x cm) 72161 4 x 4 in. ( x cm) 72160 4 x 8 in. ( x cm) 7216300 A622 0.8 x 19.7 in. (2 x 0 cm) 7216600 A6266 2 x 78.7 in. ( x 0 cm) 7216700 A6266 1.6 x 2.4 in. (4 x 6.1 cm) 72161 1.6 x 2.4 in. (4 x 6.1 cm) 72160 2.8 x 3. in. (7 x 8.9 cm) 721601 2.8 x 3. in. (7 x 8.9 cm) 721600 walnut 7216800 2 x 3 in. ( x 7.6 cm) 72660 A66 Sorbact impregnated ribbon gauze Cavity wounds of all kinds Swabs Flat, folded dressing Deep or superficial wounds Quickly Binds Bacteria Improves Healing Time Round swabs Sorbact impregnated acetate round swabs Deep or superficial wounds WCL Sorbact impregnated acetate fabric Shallow wounds and under compression Gel Ready-to-use Combines Sorbact dressing with preservative-free hydrogel Moist wound management Promotes autolytic debridement Sloughy or partly necrotic wounds. Naturally Safe and Effective No Known Risk of Bacterial Resistance Redefining Infection Management Post-Op Made of DACC impregnated acetate tissue with absorbent pad and transparent film border Surgical incisions, abrasions and traumatic wounds 70 (14 x ) 4 x 4 in. ( x cm) 72661 A66 4 x in. ( x 12.7 cm) 72662 A67 4 x 8 in. ( x cm) 72663 A67 6 x 6 in. (1 x 1 cm) 72664 A67 8 x 8 in. ( x cm) 7266 A68 3 x 3 in. (7.6 x 7.6 cm) 72610 A6231 3 x 6 in. (7.6 cm x 1 cm) 72611 A6232 2 x 3 in. 7619900 3 x 4 in. 7619901 A63 3 x 6 in. 7619902 A63 4 x 8 in. 7619903 A63 4 x in. 7619904 A64 4 x 12 in. 761990 A64 4 x 14 in. 7619906 A64 Please refer to the product label and/or package insert for full instructions on the safe use of these products. * This document includes codes that might be used to bill for BSN medical products and related services. It is the provider s sole responsibility to determine and submit appropriate codes, charges, and modifiers for services rendered. BSN medical Inc. cannot guarantee coverage or reimbursement.

Proprietary catches or binds bacteria and removes it from the wound bed versus killing it, like silver and other antimicrobial dressings. This helps to keep the cell wall intact, allowing for natural healing and long-term prevention of infections, across the wound care continuum. Quickly Binds Bacteria Catches and Inactivates Bacteria DACC (dialkylcarbamoylchloride) is a highly hydrophobic fatty acid derivative, that wound bacteria find very attractive Bacteria become irreversibly bound to the DACC-coated dressing fibers, and to each other, so they are unable to move back to the wound bed Bacteria become inactive, preventing toxin release and replication DACC-Coated Dressing microbes Hydrophobic Interaction Removal of DACC-Coated Dressing and microbes wound wound wound Faster bacteria removal promotes faster wound healing 1 In the first 30 seconds, one square centimeter of Cutimed Sorbact binds up to 0,000 ( ) wound bacteria Binding Speed 0,000,000,000,000 1,000,000 After two hours, up to 0,000,000 ( 8 ) more microbes are bound 0,000 Effectively binds MRSA and VRE after 30 sec after 2 hr 0% S. aureus P. aeruginosa

Creating Optimal Conditions for Wound Healing uses the physical property of hydrophobic interaction to promote bacteria binding just like oil droplets attach to each other in water. The bacterial pathogens are then removed with each dressing change, reducing the overall bacterial load and creating optimal conditions for natural wound healing. Improves Healing Time Wound treated 2 months with silver. Debrided wound treated with DACC-coated dressing (twice a week). Proven to Improve Healing Time by % 2 Clinical evidence comparing wounds treated with silver and wounds treated by demonstrated a % reduction in healing time 12 days vs. days. 12 Days vs. Days

Manages Bioburden With a Different Mode of Action Physical vs. Chemical When topical antimicrobial products such as silver, kill bacteria or fungi they disrupt the cell wall and release endotoxins and debris into the wound bed. This can cause the body to go into an inflammatory response, ultimately delaying wound healing 3. releases no chemical agents to fight bacteria and fungi which makes it a uniquely safe and effective wound treatment option for colonized, highly colonized and infected wounds. An illustration of endotoxin release with silver s mode of action. Naturally Safe & Effective DACC SILVER No Known Cytotoxicity No Systemic Absorption X X Effective Against Fungi X X For Use on Colonized or X X Infected Wounds Reduces Overall Bioburden X X No Complications From Infection 2 In a study of 80 patients, 0% treated with silver and 0% treated with for four months, 12 of 38 patients treated with silver developed signs of infection. Of patients treated with, there were zero complications by infection.

Even Binds Superbugs MRSA and VRE Though MRSA (methicillin-resistant Staph. Aureus) and VRE (vancomycin-resistant Enterococcus) are resistant to antibiotics, they are also hydrophobic and will bind to with no known risk of resistance. DACC-Coated Dressings Are Effective in the Removal of Bacteria From Wound Beds, Including MRSA 4 An in-vitro study that concluded A quantitatively high and stable initial adhesion to the microbial binding dressing was detected in all experiments involving Staph. Aureus strains, including nine MRSA strains. These findings strengthen the view that development of antibiotic resistance has minimal impact on the surface structures of the microorganism from a wound adhesion perspective. No Known Risk of Bacterial Resistance Studies prove that bacterial microbes are becoming more resistant to silver impregnated dressings. The hydrophobic binding mode of action of means there will likely be no development of bacterial resistance. Without a limited duration of use, can be used throughout the healing process to prevent further infection. Local Systemic Contamination Colonized Critically Colonized Infection

Cutimed Sorbact Dressing Pads Absorbent core Exudate management Ribbon gauzes Size REF-No. Dressings/Box Suggested HCPCS* 2.8 x 3. in. (7 x 8.9 cm) 72161 2.8 x 3. in. (7 x 8.9 cm) 72160 4 x 4 in. ( x cm) 72161 4 x 4 in. ( x cm) 72160 4 x 8 in. ( x cm) 7216300 A622 0.8 x 19.7 in. (2 x 0 cm) 7216600 A6266 2 x 78.7 in. ( x 0 cm) 7216700 A6266 1.6 x 2.4 in. (4 x 6.1 cm) 72161 1.6 x 2.4 in. (4 x 6.1 cm) 72160 2.8 x 3. in. (7 x 8.9 cm) 721601 2.8 x 3. in. (7 x 8.9 cm) 721600 walnut 7216800 2 x 3 in. ( x 7.6 cm) 72660 A66 Sorbact impregnated ribbon gauze Cavity wounds of all kinds Swabs Flat, folded dressing Deep or superficial wounds Quickly Binds Bacteria Improves Healing Time Round swabs Sorbact impregnated acetate round swabs Deep or superficial wounds WCL Sorbact impregnated acetate fabric Shallow wounds and under compression Gel Ready-to-use Combines Sorbact dressing with preservative-free hydrogel Moist wound management Promotes autolytic debridement Sloughy or partly necrotic wounds. Naturally Safe and Effective No Known Risk of Bacterial Resistance Redefining Infection Management Post-Op Made of DACC impregnated acetate tissue with absorbent pad and transparent film border Surgical incisions, abrasions and traumatic wounds 70 (14 x ) 4 x 4 in. ( x cm) 72661 A66 4 x in. ( x 12.7 cm) 72662 A67 4 x 8 in. ( x cm) 72663 A67 6 x 6 in. (1 x 1 cm) 72664 A67 8 x 8 in. ( x cm) 7266 A68 3 x 3 in. (7.6 x 7.6 cm) 72610 A6231 3 x 6 in. (7.6 cm x 1 cm) 72611 A6232 2 x 3 in. 7619900 3 x 4 in. 7619901 A63 3 x 6 in. 7619902 A63 4 x 8 in. 7619903 A63 4 x in. 7619904 A64 4 x 12 in. 761990 A64 4 x 14 in. 7619906 A64 Please refer to the product label and/or package insert for full instructions on the safe use of these products. * This document includes codes that might be used to bill for BSN medical products and related services. It is the provider s sole responsibility to determine and submit appropriate codes, charges, and modifiers for services rendered. BSN medical Inc. cannot guarantee coverage or reimbursement.

Proven Clinical Outcomes Proof of Bacteria-Binding1 In the first 30 seconds, 1 square centimeter of Cutimed Sorbact binds wound bacteria - after 2 hours, the amount of bacteria bound are more than would normally be found in an infected wound. Bound bacteria become inactivated, their metabolism slows down, they take a rest and do not continue to replicate. The formation of bacterial toxins also slows or stops completely which supports the wound healing process. In a lab porcine model, DACC-coated dressing showed more bacteria was removed than with Actisorb (non-dacc). Even Binds the Superbugs, MRSA4 DACC-coated dressings are effective in the removal of bacteria from wound beds, including MRSA. An in-vitro study that concluded A quantitatively high and stable initial adhesion to the microbial binding dressing was detected in all experiments involving Staphylococcus aureus strains, including nine MRSA strains. These findings strengthen the view that development of antibiotic resistance has minimal impact on the surface structures of the microorganism from a wound adhesion perspective. DACC vs. Silver 2 No signs of infection and cut the healing time by %. 80 patients - 0% treated with silver, 0% treated with. Patients were observed until wound healed, or total time of 4 months. Of the patients treated with silver, 12 of 38 patients developed signs of infection and the average healing time was days. Of the patients treated with, there were zero complications by infection and the average healing time was 12 days. Prevents Infection Equally effective to standard of care in preventing infections. 2,441 infants participated DACC was compared to the standard of care, chlorhexidine-ethanol antimicrobial. Cutimed Sorbact coated with was proven to be equally effective to standard of care in preventing infections with the purpose of preventing bacterial colonization in the umbilical area. Safe and Effective Wound Healing6 93% of the wounds improved or healed completely in the documented period. In the Kammerlander multi-center study with 116 colonized or infected wounds, Cutimed Sorbact with DACC Technology eliminated the infection signs in the majority of patients. Reduces Exudate, Odor and Pain7 Medical personal have reported exudate levels greatly improved, even for long-standing wounds that did not respond to prior treatments. Studies also show a considerable reduction in malodor in just over four weeks with Cutimed Sorbact and patients reported a significant reduction in pain over the treatment period. 1 RCT 7+ Peer-Reviewed Articles 2+ Posters + Case Studies 1. Ljungh, A. Yanagisawa, N. and Wadstrom, T. Using the principle of hydrophobic interaction to bind and remove wound bacteria. The Journal of Wound Care, April 06, Vol 1, No.4. 2. Corsi, Alessandro. Comparison of a novel non-mediated bacteria-binding dressing to silver dressings in the management of acute and chronic skin lesions. 3. Edwards R, Harding KG. (04). Bacteria and wound healing. Curr Opin Infect Dis 17:91-96. 4. Ronner, A.C., et.al.: Adhesion of methicillin-resistant Staphylococcus aureus to DACC-coated dressings, Journal of Wound Care, Vol. 23 / No., October 14.. Meberg A, Schoyen K. Hydrophobic material in routine umbilical cord care and prevention of infections in newborn infants. Scand J Infect Dis 22. 6. Kammerlander, G., Locherer, E., Süss-Burghart, A., von Hallern, B., Wipplinger, P. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. 7. Hampton, S. An evaluation of the efficacy of Cutimed Sorbact in different types of non-healing wounds. Wound UK. 07;3:1-6. BSN medical Inc. 82 Carnegie Blvd. Charlotte, NC 289-4633 Tel. 704 4 9933 Fax 704 38 48 www.bsnmedical.com To order toll-free: BSN medical 800 2 117 67 RN 1 BSN medical Inc. REV 03/1 Redefining Infection Management